Argolyn Bioscience Company
Argolyn Bioscience is a biotechnology company that develops peptide drug candidates to treat serious diseases and disorders
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Durham, North Carolina, United States
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership